Document Detail

Effect of fetal dexamethasone exposure on the development of adult insulin sensitivity in a rat model.
MedLine Citation:
PMID:  18828053     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: A rat model was designed to determine if fetal dexamethasone exposure is associated with decreased insulin sensitivity in adulthood, manifested as decreased binding of p85 to phosphorylated insulin receptor substrate-1 (IRS-1) within the phosphatidylinositol 3-kinase (PI 3-kinase) pathway of insulin signaling. Additionally, the study investigated whether a differential effect exists in male and female rodent offspring, such that females demonstrate decreased binding of p85 to IRS-1 after exposure to dexamethasone in utero. METHODS: Timed-pregnant Sprague-Dawley rats received either tap water or dexamethasone in drinking water from day 13 of gestation until delivery. Fasting male and female offspring from each group were sacrificed on day 50 of life, and half of these rats were given insulin subcutaneously prior to sacrifice. Adipocyte, skeletal muscle, and liver cell lysates were analyzed by immunoprecipitation and Western blotting of IRS-1 and IRS-1-associated p85. RESULTS: In all tissues examined, a significant inverse relationship was found between dexamethasone treatment in utero and association of p85 with IRS-1 in adulthood. p85 association with IRS-1 was similar in tissues from fasting and insulin-stimulated states. Furthermore, tissues of male and female rats demonstrated similar binding of p85 to IRS-1. CONCLUSIONS: In a rat model, fetal exposure to dexamethasone was associated with decreased insulin signaling at the level of p85 binding to IRS-1, a proximal step in insulin signaling within the PI 3-kinase pathway. This effect did not appear to be enhanced by administration of insulin prior to sacrifice, nor was a sex-dependent differential effect noted.
Karen O'Brien; Hiroko Sekimoto; Charlotte Boney; Maureen Malee
Related Documents :
24157813 - Association between genetic variations in mtnr1a and mtnr1b genes and gestational diabe...
16230533 - Transcriptional feedback control of insulin receptor by dfoxo/foxo1.
2753233 - Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concent...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians     Volume:  21     ISSN:  1476-4954     ISO Abbreviation:  J. Matern. Fetal. Neonatal. Med.     Publication Date:  2008 Sep 
Date Detail:
Created Date:  2008-10-01     Completed Date:  2009-01-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101136916     Medline TA:  J Matern Fetal Neonatal Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  623-8     Citation Subset:  IM    
Women and Infants' Hospital of Rhode Island, Providence, RI, USA. Karen_o'
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
1-Phosphatidylinositol 3-Kinase / metabolism*
Dexamethasone / administration & dosage,  adverse effects*
Glucocorticoids / administration & dosage,  adverse effects*
Glucose Metabolism Disorders / etiology
Insulin / metabolism
Insulin Receptor Substrate Proteins / metabolism*
Prenatal Exposure Delayed Effects / chemically induced,  metabolism*
Rats, Sprague-Dawley
Reg. No./Substance:
0/Glucocorticoids; 0/Insulin Receptor Substrate Proteins; 0/Irs1 protein, rat; 11061-68-0/Insulin; 50-02-2/Dexamethasone; EC 3-Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Doppler analysis and placental nitric oxide synthase expression during fetal growth restriction.
Next Document:  Pyelonephritis during pregnancy: a cause for an acquired deficiency of protein Z.